Toxicokinetics of cocaine and metabolites: The forensic toxicological approach

Current Medicinal Chemistry

Volumn 19, Issue 33, 2012, Pages 5658-5663

  Bortolotti, F ^a   Gottardo, R ^a   Pascali, J ^a   Tagliaro, F ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Blood; Cocaine; Cocaine metabolites; Fetus fluids; Fetus tissues; Hair; Oral fluid; Review; Sweat; Toxicokinetics; Urine

Indexed keywords

ANHYDROECGONINE ETHYL ESTER; ANHYDROECGONINE METHYL ESTER; BENZOYLECGONINE; COCAINE; DRUG METABOLITE; ECGONINE; ECGONINE METHYL ESTER; HOMOCOCAINE; HYDROXYBENZOYLECGONINE; NORCOCAINE; UNCLASSIFIED DRUG;

AMNION FLUID; AREA UNDER THE CURVE; ARTICLE; BLOOD; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; FETUS; FORENSIC TOXICOLOGY; HAIR; HUMAN; MAXIMUM PLASMA CONCENTRATION; MECONIUM; NONHUMAN; SALIVA; SWEAT; TIME TO MAXIMUM PLASMA CONCENTRATION; TISSUES; TOXICOKINETICS; UMBILICAL CORD; URINE;

ANIMALS; COCAINE; DOPAMINE UPTAKE INHIBITORS; FORENSIC TOXICOLOGY; HAIR; HUMANS; SALIVA; SUBSTANCE ABUSE DETECTION;

EID: 84871268341     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712803988794     Document Type: Article

References (65)

1. Karch, S. B. In Karchs Pathology of drug Abuse, CRC press, Boca Raton, 2002, pp. 2-11.
2. Jenkins, A. J. and Cone E. J. in Drug Abuse Handbook, Karch S. B, Ed., CRC press, Boca Raton, 1998, pp. 184-187
3. Baselt, R. C. In Disposition of toxic drugs and chemicals in man, Biomedical Publications, Foster city, California, 2008, 8th edition, pp. 349-355.
4. Cone, E. J. Pharmacokinetics and pharmacodynamics of cocaine. J Anal Toxicol., 1995, 19, 459-478.
5. Holmstedt, B.; Lindgren, J.; Rivier, L.; Plowman, T. Cocaine in blood of coca chewers. J. Ethnopharm., 1979, 1, 69-78.
6. Clapp, L.; Martin, B.; Beresford, T. P. Sublingual Cocaine. Novel recurrence of an ancient practice. Clin Neuropharmacol., 2004, 27, 93-94.
7. Wang, Q.; Simpao, A.; Sun, L.; Falk, J. L.; Lau, C. E. Contribution of the active metabolite, norcocaine, to cocaine's effects after intravenous and oral administration in rats: pharmacodynamics. Psychopharmacology, 2001, 153:341-52.
8. Harris, D. S.; Everhart, E. T.; Mendelson. J.; Jones R. T. The pharmacology of cocaethylene in humans following cocaine and ethanol administration. Drug Alcohol Depend., 2003, 72:169-182.
9. Herbst, E. D.; Harris, D. S.; Everhart, E. T.; Mendelson, J.; Jacob, P.; Jones, R. T. Cocaethylene formation following ethanol and cocaine administration by different routes. Exp Clin Psychopharmacol., 2011, 19:95-104.
10. Rush, C. R.; Roll, J. M.; Higgins, S. T. In Cocaine Abuse, Behavior, Pharmacology, and Clinical Applications, Higgins S. T. and Katz J. L., Eds., Academic Press, San Diego, California, 1998, p. 248.
11. Musshoff, F. Chromatographic methods for the determination of markers of chronic and acute alcohol consumption. J. Chromatogr. B, 2002, 781:457-480.
12. Politi, L.; Zucchella, A.; Morini, L.; Stramesi, C.; Polettini, A. Markers of chronic alcohol use in hair: comparison of ethyl glucuronide and cocaethylene in cocaine users. Forensic Sci Int., 2007, 172:23-27.
13. Scheidweiler, K. B.; Plessinger, M. A.; Shojaie, J.; Wood, R. W.; Kwong, T. C. Pharmacokinetics and pharmacodynamics of methylecgonidine, a crack cocaine pyrolyzate. J Pharmacol Exp Ther., 2003, 307:1179-1187.
14. Garcia, R. C.; Dati, L. M.; Fukuda, S.; Torres, L. H.; Moura, S.; de Carvalho, N. D.; Carrettiero, D. C.; Camarini, R.; Levada-Pires, A. C.; Yonamine, M.; Neto, O. N.; Abdalla, F. M.; Sandoval, M. R.; Afeche, S. C.; Marcourakis, T. The neurotoxicity of anhydroecgonine methyl ester, a crack cocaine pyrolysis product. Toxicol Sci., 2012, 128:223-234.
15. Cone, E. J.; Hillsgrove, M.; Darwin, W. D. Simultaneous measurement of cocaine, cocaethylene, their metabolites, and "crack" pyrolysis products by gas chromatography-mass spectrometry. Clin Chem., 1994, 40:1299-3051
16. Kintz, P.; Sengler, C.; Cirimele, V.; Mangin, P. Evidence of crack use by anhydroecgonine methylester identification. Hum Exp Toxicol., 1997, 16:123-127.
17. Ragoucy-Sengler, C.; Kintz, P. Detection of smoked cocaine marker (anhydroecgonine methylester) in nails. J Anal Toxicol., 2005, 29:765-768.
18. Myers, A. L.; Williams, H. E.; Kraner, J. C.; Callery, P. S. Identification of anhydroecgonine ethyl ester in the urine of a drug overdose victim. J Forensic Sci., 2005, 50:1481-1485.
19. Huestis, M. A.; Darwin, W. D.; Shimomura, E.; Lalani, S. A.; Trinidad, D. V.; Jenkins, A. J.; Cone, E. J.; Jacobs, A. J.; Smith, M. L.; Paul, B. D. Cocaine and metabolites urinary excretion after controlled smoked administration. J Anal Toxicol., 2007, 31:462-468.
20. Smith, M. L.; Shimomura, E.; Paul, B. D.; Cone, E. J.; Darwin, W. D.; Huestis, M. A. Urinary excretion of ecgonine and five other cocaine metabolites following controlled oral, intravenous, intranasal, and smoked administration of cocaine. J Anal Toxicol., 2010, 34:57-63.
21. Cone E. J.; Sampson-Cone A. H.; Darwin, W. D.; Huestis, M. A.; Oyler, J. M. Urine testing for cocaine abuse: metabolic and excretion patterns following different routes of administration and methods for detection of falsenegative results. J Anal Toxicol., 2003, 27:386-401.
22. Verstraete, A. G. Oral fluid testing for driving under the influence of drugs: history, recent progress and remaining challenges. Forensic Sci Int., 2005, 150:143-50.
23. Cooper, G.; Moore, C.; George, C.; Pichini, S. European Workplace Drug Testing Society. Guidelines for European workplace drug testing in oral fluid. Drug Test Anal., 2011, 3:269-276.
24. Drummer O. H. Drug testing in oral fluid. Clin Biochem Rev. 2006 27:147-59.
25. Bosker, W. M.; Huestis, M. A. Oral fluid testing for drugs of abuse. Clin Chem. 2009 55:1910-1931.
26. Strano-Rossi, S.; Castrignanò, E.; Anzillotti, L.; Serpelloni, G.; Mollica, R.; Tagliaro, F.; Pascali, J. P.; di Stefano, D.; Sgalla, R.; Chiarotti, M. Evaluation of four oral fluid devices (DDS (®), Drugtest 5000 (®), Drugwipe 5+ (®) and RapidSTAT (®)) for on-site monitoring drugged driving in comparison with UHPLC-MS/MS analysis. Forensic Sci Int. 2012 May 1. [in press]
27. Vanstechelman, S.; Isalberti, C.; Van der Linden, T.; Pil, K.; Legrand, S. A.; Verstraete, A. G. Analytical evaluation of four on-site oral fluid drug testing devices. J Anal Toxicol., 2012, 36:136-140.
28. Blencowe, T.; Pehrsson, A.; Lillsunde, P.; Vimpari, K.; Houwing, S.; Smink, B.; Mathijssen, R.; Van der Linden, T.; Legrand, S. A.; Pil, K.; Verstraete, A. An analytical evaluation of eight on-site oral fluid drug screening devices using laboratory confirmation results from oral fluid. Forensic Sci Int., 2011, 208:173-179.
29. Drummer, O. H. Review: Pharmacokinetics of illicit drugs in oral fluid. Forensic Sci Int., 2005, 150:133-421
30. Cone, E. J.; Clarke, J.; Tsanaclis, L. Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid. J Anal Toxicol., 2007, 31:424-433.
31. Verstraete, A. G. Detection times of drugs of abuse in blood, urine, and oral fluid. Ther Drug Monit., 2004, 26:200-205.
32. Jufer R.; Walsh S. L.; Cone, E. J., Sampson-Cone A. Effect of repeated cocaine administration on detection times in oral fluid and urine. J Anal Toxicol., 2006, 30:458-462.
33. Scheidweiler, K. B.; Spargo, E. A.; Kelly, T. L.; Cone, E. J.; Barnes, A. J.; Huestis, M. A. Pharmacokinetics of cocaine and metabolites in human oral fluid and correlation with plasma concentrations after controlled administration. Ther Drug Monit., 2010, 32:628-637.
34. Cone, E. J.; Oyler, J.; Darwin, W. D. Cocaine disposition in saliva following intravenous, intranasal, and smoked administration. J Anal Toxicol., 1997, 21:465-75.
35. Toennes, S. W.; Kauert, G. F.; Steinmeyer, S.; Moeller, M. R. Driving under the influence of drugs - evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms. Forensic Sci Int., 2005, 152:149-155.
36. Villain, M.; Cirimele, V.; Kintz, P. Hair analysis in toxicology. Clin Chem Lab Med., 2004, 42:1265-1272.
37. Kintz P. Value of the concept of minimal detectable dosage in human hair. Forensic Sci Int., 2012, 218:28-30.
38. Wang, W. L.; Cone, E. J. Testing human hair for drugs of abuse. IV. Environmental cocaine contamination and washing effects. Forensic Sci Int., 1995, 70:39-51.
39. SAHMSA (Substance Abuse and Mental Health Services Administration). Notice of proposed revisions to the mandatory guidelines for federal workplace drug testing programs. Fed. Regist., 2004, 69:19673-19732.
40. Stout, P. R.; Ropero-Miller, J. D.; Baylor, M. R.; Mitchell J. M. External contamination of hair with cocaine: evaluation of external cocaine contamination and development of performance-testing materials. J Anal Toxicol. 2006 30:490-500.
41. Ropero-Miller J. D.; Huestis M. A.; Stout, PR. Cocaine Analytes in Human Hair: Evaluation of Concentration Ratios in Different Cocaine Sources, Drug-User Populations and Surface-Contaminated Specimens. J Anal Toxicol. 2012, 36:390-398.
42. Pragst, F.; Sachs, H.; Kintz, P. Hair analysis for cocaine continues to be a valuable tool in forensic and clinical toxicology. J Anal Toxicol., 2010, 34:354-355
43. Le Beau, M. A.; Montgomery M. A. Considerations on the utility of hair analysis for cocaine. J Anal Toxicol., 2009, 33:343-344.
44. Kintz, P.; Villain, M.; Cirimele. V. Hair analysis for drug detection. Ther Drug Monit., 2006, 28:442-446.
45. Nakahara, Y.; Takahashi, K.; Kikura, R. Hair analysis for drugs of abuse. X. Effect of physicochemical properties of drugs on the incorporation rates into hair. Biol Pharm Bull., 1995, 18:1223-1227.
46. Nakahara, Y.; Ochiai, T.; Kikura, R. Hair analysis for drugs of abuse. V. The facility in incorporation of cocaine into hair over its major metabolites, benzoylecgonine and ecgonine methyl ester. Arch Toxicol. 1992;66:446-449.
47. Hubbard, D. L.; Wilkins, D. G.; Rollins, D. E. The incorporation of cocaine and metabolites into hair: effects of dose and hair pigmentation. Drug Metab Dispos., 2000, 28:1464-1469.
48. Garcia-Bournissen, F.; Moller, M.; Nesterenko, M.; Karaskov, T.; Koren G. Pharmacokinetics of disappearance of cocaine from hair after discontinuation of drug use. Forensic Sci Int., 2009, 189:24-27.
49. Felli, M.; Martello, S.; Marsili, R.; Chiarotti, M. Disappearance of cocaine from human hair after abstinence. Forensic Sci Int. 2005, 154:96-98.
50. Koren, G. Measurement of drugs in neonatal hair; a window to fetal exposure. Forensic Sci Int., 1995, 70:77-82.
51. Koren, G.; Chan, D.; Klein, J.; Karaskov, T. Estimation of fetal exposure to drugs of abuse, environmental tobacco smoke, and ethanol. Ther Drug Monit., 2002, 24:23-25.
52. Sallee, F. R.; Katikaneni, L. P.; McArthur, P. D.; Ibrahim, H. M., Nesbitt, L., Sethuraman, G. Head growth in cocaine-exposed infants: relationship to neonate hair level. J Dev Behav Pediatr., 1995 16:77-81.
53. Bateman, D. A.; Chiriboga, C. A. Dose-response effect of cocaine on newborn head circumference. Pediatrics., 2000, 106:E33.
54. Kuhn, L.; Kline, J., Ng, S., Levin, B., Susser, M. Cocaine use during pregnancy and intrauterine growth retardation: new insights based on maternal hair tests. Am J Epidemiol., 2000, 152:112-119.
55. Askin, D. F.; Diehl-Jones, B. Cocaine: effects of in utero exposure on the fetus and neonate. J Perinat Neonatal Nurs., 2001, 14:83-102.
56. Koren, G., Klein, J., McMartin, K. Diagnosing intrauterine exposure to cocaine by hair testing: six years of clinical use. Ther Drug Monit., 1998, 20:478-480.
57. Garcia-Bournissen, F.; Rokach, B.; Karaskov, T.; Koren G. Cocaine detection in maternal and neonatal hair: implications to fetal toxicology. Ther Drug Monit., 2007, 29:71-76.
58. Morishima, H. O.; Okutomi, T.; Whittington, R. A.; Cooper, T. B. Doserelated differences in the distribution of cocaine in the maternal-fetoplacental compartments in rats. Neurotoxicol Teratol., 2000 22:837-844.
59. Zhou, M.; Song, Z. M.; Lidow, M. S. Pharmacokinetics of cocaine in maternal and fetal rhesus monkeys at midgestation. J Pharmacol Exp Ther., 2001, 297:556-562.
60. Gareri, J.; Klein, J.; Koren, G. Drugs of abuse testing in meconium. Clin Chim Acta., 2006, 366:101-111.
61. Montgomery, D. P.; Plate, C. A.; Jones, M.; Jones, J.; Rios, R.; Lambert, D. K.; Schumtz, N.; Wiedmeier, S. E.; Burnett, J.; Ail, S.; Brandel, D.; Maichuck, G.; Durham, C. A.; Henry, E.; Christensen, R. D. Using umbilical cord tissue to detect fetal exposure to illicit drugs: a multicentered study in Utah and New Jersey. J Perinatol., 2008, 28:750-753.
62. Oyler, J.; Darwin, W. D.; Preston, K. L.; Suess, P.; Cone, EJ. Cocaine disposition in meconium from newborns of cocaine-abusing mothers and urine of adult drug users. J Anal Toxicol., 1996 20:453-462.
63. Winecker, R. E.; Goldberger, B. A.; Tebbett, I.; Behnke, M.; Eyler, F. D.; Conlon, M.; Wobie, K.; Karlix, J.; Bertholf, R. L. Detection of cocaine and its metabolites in amniotic fluid and umbilical cord tissue. J Anal Toxicol., 1997 21:97-104.
64. Huestis, M. A.; Cone, E. J. in Drug Abuse Handbook, Karch S. B, Ed., CRC press, Boca Raton, 1998, pp. 799-857.
65. Kacinko, S. L.; Barnes, A. J.; Schwilke, E. W.; Cone, E. J.; Moolchan, E. T.; Huestis, M. A.. Disposition of cocaine and its metabolites in human sweat after controlled cocaine administration. Clin Chem., 2005 51:2085-2094.